DentistryNeck SurgeryOncologyNeck OncologySalivary Gland DisordersSalivary Gland SurgeryBenign Salivary Gland TumorsMalignant Salivary Gland TumorsSalivary Gland CancerSalivary Gland MalignanciesSalivary Gland PathologySalivary GlandsActuarial Survival AnalysisBenign Salivary Gland LesionsMalignant Salivary Gland LesionsMalignant Salivary Gland NeoplasmsMedian AgePrimary Tumor AssessmentRetrospective Record Review
A retrospective review of 643 patients with salivary gland tumors seen between 1958-72 is reported. There were 328 malignant and 375 benign tumors. All patients with malignant tumors were assessed in a multidisciplinary head and neck clinic. The median age for developing malignant tumors was 58 and there was a male to female ratio of 1.2:1. For benign tumors the median age was 46 years and the male to female ratio 0.8:1. Overall the primary tumor was controlled by the first planned treatment in 145 (44%) malignant tumors and in 253 (80%) benign tumors. The five and 10 year actuarial survival for malignant tumors was 59.4% and 45.6% respectively.